Boothbay Fund Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Boothbay Fund Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,600	Closed	-$978K	–	2603
2023 Q1	$978K	Buy	+40,600	New	+$509K	0.02%	995

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Boothbay Fund Management's PRVB Position: Q2 2023 in Review

Boothbay Fund Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 40,600 shares — an estimated $978K sold.

Boothbay Fund Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $978K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Boothbay Fund Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 40,600 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $978K.
Boothbay Fund Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Boothbay Fund Management's Provention Bio, Inc. Common Stock position peaked at $978K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.